LIBERTY PARTNERS GROUP, LLC

Lobbying for TELIX PHARMACEUTICALS US · Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Indiana · House · Senate · posted Oct 20, 2025

Lobbying activity 3

Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.